abstract |
Disclosed is a novel use of chloride channel openers, particularly prostaglandin compounds, for the treatment of abdominal discomfort. Further disclosed are novel uses of chloride channel openers, particularly prostaglandin compounds, for the treatment of functional gastrointestinal diseases. |